NewAmsterdam Pharma Stock (NASDAQ: NAMS) stock price, news, charts, stock research, profile.
You can purchase shares of NewAmsterdam Pharma (NASDAQ:NAMS) through any online brokerage.
Other companies in NewAmsterdam Pharma’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Centessa Pharmaceuticals (NASDAQ:CNTA), Syndax Pharmaceuticals (NASDAQ:SNDX) and Day One Biopharmaceutical (NASDAQ:DAWN).
NewAmsterdam Pharma has a consensus price target of $29.25.
The stock price for NewAmsterdam Pharma (NASDAQ: NAMS) is $17.65 last updated October 31, 2024 at 12:17 PM EDT.
There are no upcoming dividends for NewAmsterdam Pharma.
NewAmsterdam Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for NewAmsterdam Pharma.
NewAmsterdam Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.